Advertisement
Screener

Celularity Inc. (CELU) Form NT 10-Q: Notification of late filing: quarterly report

Celularity Inc. Form NT 10-Q: Notification of late filing: quarterly report

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2026-08-14: Form NT 10-Q; Period of report 2026-06-30; Description NT 10-Q; Document formnt10-q.htm.
  • 2026-05-15: Form NT 10-Q; Period of report 2026-03-31; Description NT 10-Q; Document formnt10-q.htm.
  • 2024-11-15: Form NT 10-Q; Period of report 2024-09-30; Description Notification of late filing: quarterly report; Document formnt10-q.htm.
  • 2024-08-16: Form NT 10-Q; Period of report 2024-06-30; Description Notification of late filing: quarterly report; Document formnt10-q.htm.
FiledFormPeriod of reportDescriptionDocument
2026-08-14NT 10-Q2026-06-30NT 10-Qformnt10-q.htm
2026-05-15NT 10-Q2026-03-31NT 10-Qformnt10-q.htm
2024-11-15NT 10-Q2024-09-30Notification of late filing: quarterly reportformnt10-q.htm
2024-08-16NT 10-Q2024-06-30Notification of late filing: quarterly reportformnt10-q.htm
2024-05-15NT 10-Q2024-03-31Notification of late filing: quarterly reportformnt10-q.htm
2023-11-14NT 10-Q2023-09-30NT 10-Qd550316dnt10q.htm
2023-05-15NT 10-Q2023-03-31NT 10-Qd504365dnt10q.htm
2021-08-16NT 10-Q2021-06-30NOTIFICATION OF LATE FILINGea145941-nt10q_celularityinc.htm
2021-05-18NT 10-Q2021-03-31NOTIFICATION OF LATE FILINGea141080-nt10q_gxacquisition.htm

Similar stocks

Stock NameCountryMarket CapPE Ratio
CervoMed Inc. (CRVO)United States$0.038B-1.39
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
PMGC Holdings Inc. (ELAB)United States$0.037B
Edesa Biotech, Inc. (EDSA)Canada$0.039B
BriaCell Therapeutics Corp. (BCTX)$0.037B
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
Incannex Healthcare Inc. (IXHL)$0.040B-22.32